BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 35316258)

  • 21. Meta-analysis of type-specific human papillomavirus prevalence in Iranian women with normal cytology, precancerous cervical lesions and invasive cervical cancer: Implications for screening and vaccination.
    Jalilvand S; Shoja Z; Nourijelyani K; Tohidi HR; Hamkar R
    J Med Virol; 2015 Feb; 87(2):287-95. PubMed ID: 25156655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinical utility of extended high-risk HPV genotyping in risk-stratifying women with L-SIL cytology: A retrospective study of 8726 cases.
    Tao X; Zhang H; Zhang H; Xiao Y; Zhong F; Zhou X; Cong Q; Sui L; Zhao C
    Cancer Cytopathol; 2022 Jul; 130(7):542-550. PubMed ID: 35312217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand.
    Simonella LM; Lewis H; Smith M; Neal H; Bromhead C; Canfell K
    BMC Infect Dis; 2013 Mar; 13():114. PubMed ID: 23452957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
    Latsuzbaia A; Hebette G; Fischer M; Arbyn M; Weyers S; Vielh P; Schmitt F; Mossong J
    Diagn Cytopathol; 2017 May; 45(5):384-390. PubMed ID: 28247516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discrepancy between Cytology and Histology in Cervical Cancer Screening: a Multicenter Retrospective Study (KGOG 1040).
    Ouh YT; Park JJ; Kang M; Kim M; Song JY; Shin SJ; Shim SH; Yoo HJ; Lee M; Lee SJ; Shin W; Chong GO; Choi MC; Choi CH; Min KJ
    J Korean Med Sci; 2021 Jun; 36(24):e164. PubMed ID: 34155836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing.
    Sherman ME; Schiffman MH; Lorincz AT; Herrero R; Hutchinson ML; Bratti C; Zahniser D; Morales J; Hildesheim A; Helgesen K; Kelly D; Alfaro M; Mena F; Balmaceda I; Mango L; Greenberg M
    Cancer; 1997 Apr; 81(2):89-97. PubMed ID: 9126136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A population-based study of human papillomavirus genotype prevalence in the United States: baseline measures prior to mass human papillomavirus vaccination.
    Wheeler CM; Hunt WC; Cuzick J; Langsfeld E; Pearse A; Montoya GD; Robertson M; Shearman CA; Castle PE;
    Int J Cancer; 2013 Jan; 132(1):198-207. PubMed ID: 22532127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of non 16/18 high risk human papilloma virus as a quality metric in gynecological cytology.
    Aly FZ; Irhayyim A; Jordan R; Mukhtar F; Klein R
    Diagn Cytopathol; 2024 Jul; 52(7):377-380. PubMed ID: 38651180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of atypical and low-grade cervical cytology in private practice.
    Nyirjesy I; Billingsley FS; Forman MR
    Obstet Gynecol; 1998 Oct; 92(4 Pt 1):601-7. PubMed ID: 9764636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human Papillomavirus Genotyping to Predict the Risk of Cervical Precancerous Lesions or Cancer in Women with Minor Abnormal Cytology in China.
    Lin CQ; Cui JF; Zhang X; Pan QJ; Chen W; Qiao YL
    Acta Cytol; 2015; 59(5):405-11. PubMed ID: 26565687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human papillomavirus 16/18 seroprevalence in unvaccinated women over 30 years with normal cytology and with high grade cervical abnormalities in Australia: results from an observational study.
    Velentzis LS; Sitas F; O'Connell DL; Darlington-Brown J; Egger S; Sinha R; Banks E; Frazer IH; Canfell K
    BMC Infect Dis; 2014 Dec; 14():3861. PubMed ID: 25528152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-risk human papillomavirus cervical infections among healthy women in Guadeloupe.
    Cordel N; Ragin C; Trival M; Tressières B; Janky E
    Int J Infect Dis; 2015 Dec; 41():13-6. PubMed ID: 26597118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The age-specific relationships of abnormal cytology and human papillomavirus DNA results to the risk of cervical precancer and cancer.
    Castle PE; Fetterman B; Thomas Cox J; Shaber R; Poitras N; Lorey T; Kinney W
    Obstet Gynecol; 2010 Jul; 116(1):76-84. PubMed ID: 20567171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Triaging women with human papillomavirus infection and normal cytology or low-grade dyskaryosis: evidence from 10-year follow up of the ARTISTIC trial cohort.
    Gilham C; Sargent A; Peto J
    BJOG; 2020 Jan; 127(1):58-68. PubMed ID: 31541495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high risk human papillomavirus: 14 year follow-up of population based randomised cohort in the Netherlands.
    Dijkstra MG; van Zummeren M; Rozendaal L; van Kemenade FJ; Helmerhorst TJ; Snijders PJ; Meijer CJ; Berkhof J
    BMJ; 2016 Oct; 355():i4924. PubMed ID: 27702796
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human papillomavirus types distribution in organised cervical cancer screening in France.
    Heard I; Tondeur L; Arowas L; Falguières M; Demazoin MC; Favre M
    PLoS One; 2013; 8(11):e79372. PubMed ID: 24244490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cervical cytology of atypical squamous cells-cannot exclude high-grade squamous intraepithelial lesion (ASC-H): characteristics and histologic outcomes.
    Sherman ME; Castle PE; Solomon D
    Cancer; 2006 Oct; 108(5):298-305. PubMed ID: 16544318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of high-risk human papillomavirus types and cervical squamous intraepithelial lesions in women over 30 years of age in St. Petersburg, Russia.
    Shipitsyna E; Zolotoverkhaya E; Kuevda D; Nasonova V; Romanyuk T; Khachaturyan A; Orlova O; Abashova E; Kostyuchek I; Shipulina O; Anttila A; Savicheva A
    Cancer Epidemiol; 2011 Apr; 35(2):160-4. PubMed ID: 20884314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence of cervical high-grade squamous intraepithelial lesions and squamous cell carcinoma in women with high-risk human papillomavirus and normal cervical cytology: A retrospective analysis of 1858 cases stratified by age and human papillomavirus genotype.
    Gu L; Hong Z; Gao H; Qiu L; Di W
    Cytopathology; 2019 Jul; 30(4):419-425. PubMed ID: 31069857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.